US › Healthcare

Axogen Inc (AXGN)

US · Healthcare · Medical Devices

$45.96+0.50%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$69.7M
Revenue YoY
+23.1%
Net profit
$-1.5M
Profit YoY
-361.8%
EPS
$-0.03
EPS estimate
$-0.04
Net margin
-2.2%

EPS came in at -0.03 against a street estimate of -0.04 — a beat of 25.0%.

Key statistics

Market cap
$2.46B
Forward P/E
5,000.0
P/B
8.86
Book value
$4.78
EPS (TTM)
$-0.67
52-week high
$46.95
52-week low
$13.46
50-day MA
$41.99
200-day MA
$34.07
Beta
1.14

Analyst view

Analysts rate Axogen Inc a strong buy (7 buy, 0 hold, 0 sell out of 7) with an average price target of $53.22.

Shareholding

Insiders
2.16%
Institutions
95.91%

Largest institutional holders

FundStake
First Light Asset Management, LLC7.45%
BlackRock Inc7.20%
Morgan Stanley - Brokerage Accounts5.81%
Vanguard Capital Management, LLC4.26%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)3.56%
Polar Capital Holdings PLC2.79%
Artemis Investment Management LLP2.60%
FMR Inc2.44%

Recent filings & reports

DocumentDate
Quarterly report · Q2 20262026-07-29
Results announced · Q3 20262026-07-29
Shareholder vote results · Q2 20262026-06-23
Proxy statement · Q4 20252026-04-29
Quarterly report · Q1 20262026-04-28
Results announced · Q2 20262026-04-28
Annual report FY20252026-02-24
Results announced · Q1 20262026-02-24

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Axogen Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.